New study published in Translational Medicine highlights cell avidity's power as a functional biomarker for improved CAR-T design in preventing tumor escape
/PRNewswire/ -- LUMICKS, a next generation life science tools company, today announced that research findings from a consortium, led by researchers at Cancer...